IMPREP PROJECT: PRESENT AT AIDS 2026
Acceptability and Usability of Blood-Based and Oral Fluid HCV Self-Testing Among Men-Who-Have-Sex-with-Men and Transgender Women on PrEP
Person-centered choice and mHealth support for same-day delivery of long-acting injectable cabotegravir (ImPrEP CAB Brasil): a prospective, open-label, multicenter, quasi-experimental implementation study
Characterization of HIV acquisitions during a large oral PrEP implementation study: insights from the ImPrEP study
